Glenmark and Helsinn Group to Anti-Nausea Drug in India and Nepal
Mumbai-based Glenmark Pharmaceuticals Ltd., and Switzerland’s Helsinn Group, have announced that they have entered into an exclusive licensing agreement to introduce Akynzeo, an oral fixed combination of netupitant (300-mg) and palonosetron (0.5-mg) in capsule form in India and Nepal. The drug is used for prevention of chemotherapy-induced nausea and vomiting (CINV).
The licensing agreement represents Helsinn’s first such agreement in India, and Glenmark will have exclusive marketing rights for the drug in India and Nepal. Glenmark has received marketing approval for it from the Central Drugs Standard Control Organization (CDSCO).
Akynzeo is the first and only combination anti-emetic prophylaxis with high complete response rates for five days in cancer chemotherapy treated patients. Delayed nausea is still a problem for up to 82% of patients receiving MEC (Moderately Emetogenic Chemotherapy) and HEC (Highly Emetogenic Chemotherapy), representing a significant unmet medical need.
2026-09-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Nirma acquires majority stake in Glenmark Life Sciences
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
Chinese Urea Producers Receive a Timely Boost as Second Round of 2026 Export Quotas Nears 2 Million Tons
-
EU May Build Industry-Level Trade Barriers Against Chinese Chemicals
-
EU Low-Value Parcel Rules Could Disrupt Chemical Sample Flows
-
U.S. 10% Temporary Tariff Expires, New Section 301 Tariffs Not Yet Implemented
-
What Can $3.4 Billion Buy? Shin-Etsu Chemical’s Answer: Upstream Control of PVC
-
Ukraine Strikes Russia’s Perm Refinery Again, Forcing Crude Unit Offline at 260,000-BPD Facility
-
Global Chemical Giants Accelerate Plant Closures and Layoffs as Industry Enters Structural Capacity Rationalization
-
European Diesel Crack Spread Hits Record $74.66 per Barrel as Global Refinery Outages Mount
Recommend Reading
-
Ukraine Strikes Russia’s Ryazan Refinery Again, Setting 17-Million-Tonne Facility Ablaze
-
Wanhua Chemical Raises Southeast Asia MDI and TDI Offers by $200 per Tonne
-
EU mulls expanding tariff scope on Chinese chemicals, sector-wide measures in the pipeline
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
In November, Shandong Local Refineries' Gasoline and Diesel Prices Show Divergence
-
Rate of Change Turns Negative—Retail Prices for Refined Oil Products to Be Lowered This Round
-
Weakness in China's Methanol Market Continues in November
-
Narrow Fluctuations in the MTBE Market in November in China
-
Supply and Demand Weakness, Flexible Fluctuations in the Melamine Market
- Hot Searches
- bioglutide peptide for sale
- 2cb for sale
- hypochlorous acid wholesale supplier
- sulfanilamide powder
- calcium ammonium nitrate for sale
- rubbing alcohol molecular structure
- food grade phosphoric acid
- etoricoxid
- methyl tertiary butyl ether msds
- tetramethyl butane
- urea futures price
- yttria price